← Back
Data updated: Mar 10, 2026
AFAXYS
Pharmaceuticals
AFAXYS is a generic drug manufacturer with 1 FDA-approved products.
2022
Since
1
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-07-29
LIDOCAINE HYDROCHLORIDE 2025-04-02
LIDOCAINE HYDROCHLORIDE 2024-04-29
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2022-06-09
- Latest
- 2023-02-08
- Applications
- 1